PubMed Health⌕ Search
Home/Archive/PubMed

PubMed · 15695863

Infantile cortical hyperostosis.

Sourabh Dutta·Naveen Jain·Anish Bhattacharya·Kanya Mukhopadhyay
View original source ↗Export metadata ↓

Abstract

Infantile cortical hyperostosis (Caffey disease) is characterized by radiological evidence of cortical hyperostosis, soft tissue swellings, fever and irritability. We report a case of Caffey disease highlighting its presentation as pyrexia of unknown origin, appearance on radionuclide bone scintigraphy and our unsatisfactory experience of treating it with Ibuprofen, a prostaglandin inhibitor.

Explore related subjects

Fever of Unknown OriginHumansHyperostosis, Cortical, CongenitalInfantMaleRadiographyCase ReportsJournal Article

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Sourabh Dutta, Naveen Jain, Anish Bhattacharya, Kanya Mukhopadhyay. 2005. Infantile cortical hyperostosis.. https://pubmed.ncbi.nlm.nih.gov/15695863/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2006

[Positron emission tomography: current use in internal medicine and future perspectives].

PURPOSE: Fluorodeoxyglucose positron emission tomography (FDG-PET) is a promising imaging technique that has already proven effective in modifying patient care in oncology. Fluorodeoxyglucose still remains the main radiopharmaceutical agent routinely used for PET imaging. A growing interest has recently lead to broaden PET research on benign disorders. The field of inflammatory or immune diseases and globally the field of internal medicine could also be impacted by FDG-PET. MAIN POINTS: Great vessels vasculitides and fever of unknown origin have both been studied by several teams and could become indications for PET. In addition, current indications now extend to paraneoplastic syndromes. It is thus possible to foresee that the clinical applications for PET will continue to expand in these patients. PERSPECTIVES AND PROJECTS: In the future, inflammatory arthritis, chronic inflammatory bowel diseases, systemic erythematous lupus, histiocytosis, or pulmonary and retroperitoneal fibrosis might benefit from PET even if, available data remains scarce to this day. Although PET will probably alter the landscape of patient management in internal medicine in the near future, additional clinical research is still needed to ascertain the exact role of PET.

Fever of Unknown Origin↗